Homebiogas (HMGS) AI Stock Analysis

• Market Cap: 39.56M
• Dividend Yield: N/A
• Average Volume (3M): 182.00K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.53
• Revenue Growth: -4.02%
• EPS Growth: 44.85%
• Country: IL
• Employees: 69
• Sector: Energy
• Sector Strength: 52
• Industry: Renewable Utilities
• EPS (TTM): -10.10
• Shares Outstanding: 28,336,428
• 10 Day Avg. Volume: 222,381
• 30 Day Avg. Volume: 182,002
• PEG Ratio: 0.10
• Price to Book (P/B): 3.87
• Price to Sales (P/S): 7.25
• P/FCF Ratio: -3.44
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 44 Neutral
• Price Target: 139.00 ▼(-0.57% Downside)

The overall stock score is primarily impacted by the company's weak financial performance, characterized by declining revenue, profitability, and negative cash flow. Technical analysis provides some medium-term support, but the lack of strong momentum and oversold conditions suggest caution. The valuation is further hampered by a negative P/E ratio and no dividend yield, indicating potential overvaluation or financial distress.

Homebiogas Business Overview & Revenue Model

Company Description

HomeBiogas LTD develops, produces, and markets biogas systems for treatment of organic waste into clean energy for households, farmers, businesses, and communities worldwide. The company offers HomeBiogas 2, a biogas system that recycles food scraps into free clean cooking gas and fertilizers, as well as creates renewable energy; HomeBiogas 4, recycles organic waste into renewable energy; and HomeBiogas 7, which converts manure into renewable energy and liquid fertilizers. It also provides additional products, such as countertop biogas stoves, maintenance kits, sink covers, built-in biogas stoves, filter kits, probiotic tablets, bio-toilet kits, and gas bags. The company also operates an online shop for its products. HomeBiogas LTD was incorporated in 2012 and is headquartered in Beit Yanai, Israel.

How the Company Makes Money

Homebiogas generates revenue through the sale of its biogas systems, which include both residential and commercial units designed for converting organic waste into biogas and fertilizer. The company offers various models tailored to different customer needs, including sizes suitable for single households to larger operations. Additionally, HMGS may earn income through installation services, maintenance contracts, and educational programs that promote sustainable practices. Strategic partnerships with environmental organizations, government agencies, and renewable energy initiatives further enhance its market presence and can lead to collaborative projects that provide additional funding or subsidies, contributing to overall earnings.

Homebiogas Financial Statement Overview

Summary

Homebiogas is facing financial challenges with declining revenue and profitability, alongside a weakening balance sheet and negative cash flow. The company needs to focus on improving its revenue generation and cost efficiency to stabilize its financial position and ensure long-term sustainability.

Income Statement

Homebiogas has experienced a decline in revenue from 2023 to 2024, indicating a negative growth trend. The gross profit margin has also decreased, and the company is currently operating at a loss, as evidenced by negative net profit and EBIT margins. These factors suggest challenges in achieving profitability and effective cost management.

Balance Sheet

The company's debt-to-equity ratio is relatively low, indicating a conservative use of debt. However, a significant decline in total assets and stockholders' equity from 2023 to 2024 suggests a weakening balance sheet. The equity ratio remains moderate but reflects the need for improved asset utilization and equity management.

Cash Flow

Homebiogas has shown a negative operating cash flow, indicating challenges in generating cash from operations. The free cash flow remains negative, though slightly improved from the previous year. The cash flow management needs to be enhanced to support sustainable growth and financial stability.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	2.92M	2.63M	4.83M	4.70M	2.48M	1.02M
Gross Profit	697.00K	384.00K	1.55M	1.34M	234.00K	-488.00K
EBITDA	-3.79M	-8.23M	-9.91M	-14.00M	-7.64M	-4.08M
Net Income	-5.66M	-9.42M	-11.34M	-15.16M	-8.31M	-4.22M
Balance Sheet
Total Assets	7.03M	8.21M	19.43M	19.62M	33.58M	8.94M
Cash, Cash Equivalents and Short-Term Investments	2.57M	2.84M	9.14M	11.20M	26.05M	6.77M
Total Debt	434.00K	470.00K	1.95M	1.64M	1.99M	260.00K
Total Liabilities	2.20M	3.23M	5.39M	5.23M	5.49M	2.59M
Stockholders Equity	4.77M	4.93M	14.04M	14.39M	28.09M	6.36M
Cash Flow
Free Cash Flow	-1.62M	-5.54M	-11.13M	-12.77M	-10.72M	-3.66M
Operating Cash Flow	-1.61M	-4.51M	-10.58M	-11.57M	-8.33M	-3.56M
Investing Cash Flow	32.00K	-847.00K	-571.00K	-1.13M	-2.49M	492.00K
Financing Cash Flow	39.00K	-639.00K	9.28M	-419.00K	28.77M	9.23M

Homebiogas Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 139.80
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:HMGS, the sentiment is Negative. The current price of 139.8 is below the 20-day moving average (MA) of 139.91, below the 50-day MA of 143.78, and above the 200-day MA of 137.99, indicating a neutral trend. The MACD of -1.15 indicates Negative momentum. The RSI at 47.36 is Neutral, neither overbought nor oversold. The STOCH value of 31.85 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IL:HMGS.

Homebiogas Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	65 Neutral	$15.17B	7.61	4.09%	5.20%	3.87%	-62.32%
HMGS	44 Neutral	39.56M	-1.62	―	―	-4.02%	44.85%